Homology Medicines Inc buy quelbe60
Start price
16.10.22
/
50%
€1.31
Target price
16.10.23
-
Performance (%)
-17.62%
End price
27.12.22
€1.08
Summary
This prediction ended on 27.12.22 with a price of €1.08. The price of Homology Medicines Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.62%. quelbe60 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Homology Medicines Inc | - | - | - |
| iShares Core DAX® | 1.665% | 1.692% | 18.093% |
| iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% |
| iShares Nikkei 225® | 2.620% | 4.475% | 17.651% |
| iShares S&P 500 | -0.091% | 1.099% | 24.873% |
According to quelbe60 what are the pros and cons of Homology Medicines Inc for the foreseeable future?
Pros
Cons
Risky Investment
Comments by quelbe60 for this prediction
In the thread Homology Medicines Inc diskutieren
Buy Homology Medicines Inc